Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation.

    Giovannini A, Neri P, Mercanti L, Bruè C.

    Br J Ophthalmol. 2007 May;91(5):620-3. Epub 2007 Jan 3.PMID: 17202205 [PubMed - indexed for MEDLINE]Related articles

    3.

    Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.

    Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS, Li KK.

    Ophthalmology. 2003 Dec;110(12):2395-402.PMID: 14644724 [PubMed - indexed for MEDLINE]Related articles

    4.

    Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

    Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong KK.

    Br J Ophthalmol. 2004 Oct;88(10):1315-9.PMID: 15377558 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.

    Br J Ophthalmol. 2007 Feb;91(2):174-9. Epub 2006 Sep 20.PMID: 16987898 [PubMed - indexed for MEDLINE]Related articles

    6.

    Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

    7.

    Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration.

    Pawlak D, Glacet-Bernard A, Papp M, Roquet W, Coscas G, Soubrane G.

    Am J Ophthalmol. 2004 May;137(5):880-7.PMID: 15126153 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.

    Maár N, Ergun E, Luksch A, Stur M.

    Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1262-6. Epub 2006 Mar 15.PMID: 16538450 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Two-year results of photodynamic therapy for choroidal neovascularization in young patients]

    Fujisato K, Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N.

    Nippon Ganka Gakkai Zasshi. 2008 Sep;112(9):777-85. Review. Japanese. PMID: 18833941 [PubMed - indexed for MEDLINE]Related articles

    12.

    Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.

    Chan WM, Lam DS, Lai TY, Yuen KS, Liu DT, Chan CK, Chen WQ.

    Am J Ophthalmol. 2003 Nov;136(5):836-45.PMID: 14597034 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Comparison of macular limited translocation and photodynamic therapy for management of choroidal neovascularization in degenerative myopia: a retrospective study]

    Dumas S, Glacet-Bernard A, Haddad WM, Razavi S, Roquet W, Coscas G, Soubrane G.

    J Fr Ophtalmol. 2006 Nov;29(9):980-9. French. PMID: 17114990 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.

    Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM; United Kingdom PDT Users Group.

    Ophthalmology. 2005 Jul;112(7):1227-31.PMID: 15921757 [PubMed - indexed for MEDLINE]Related articles

    15.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.

    Retina. 2006 Jul-Aug;26(6):602-12.PMID: 16829800 [PubMed - indexed for MEDLINE]Related articles

    16.

    Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.

    Glacet-Bernard A, Benyelles N, Dumas S, Haddad WM, Voigt M, Razavi S, Roquet W, Coscas G, Soubrane G.

    Am J Ophthalmol. 2007 Jan;143(1):68-76. Epub 2006 Oct 19.PMID: 17188042 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization.

    Hussain N, Das T, Rawal H, Kallukuri SB, Mohan Ram LS, Khanna R.

    Indian J Ophthalmol. 2006 Dec;54(4):247-50.PMID: 17090876 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.

    Montero JA, Ruiz-Moreno JM.

    Br J Ophthalmol. 2003 Feb;87(2):173-6.PMID: 12543746 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

    Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.

    Ophthalmology. 2004 Aug;111(8):1576-84.PMID: 15288991 [PubMed - indexed for MEDLINE]Related articles

    20.

    Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks.

    Heimann H, Gelisken F, Wachtlin J, Wehner A, Völker M, Foerster MH, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1115-23. Epub 2005 Jun 10.PMID: 15947939 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data